Mycovia Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYCOVIA PHARMS, and when can generic versions of MYCOVIA PHARMS drugs launch?
MYCOVIA PHARMS has one approved drug.
There are five US patents protecting MYCOVIA PHARMS drugs.
There are fifty-one patent family members on MYCOVIA PHARMS drugs in twenty-three countries.
Drugs and US Patents for Mycovia Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | 8,754,227 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | 8,236,962 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mycovia Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2013209516 | ⤷ Try a Trial |
Finland | 3271347 | ⤷ Try a Trial |
Eurasian Patent Organization | 026209 | ⤷ Try a Trial |
European Patent Office | 3271347 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.